- United States
- /
- Healthcare Services
- /
- NasdaqCM:DCGO
General Counsel Ely Tendler Sold A Bunch Of Shares In DocGo
We'd be surprised if DocGo Inc. (NASDAQ:DCGO) shareholders haven't noticed that the General Counsel, Ely Tendler, recently sold US$103k worth of stock at US$4.44 per share. The eyebrow raising move amounted to a reduction of 26% in their holding.
See our latest analysis for DocGo
The Last 12 Months Of Insider Transactions At DocGo
Notably, that recent sale by Ely Tendler is the biggest insider sale of DocGo shares that we've seen in the last year. So we know that an insider sold shares at around the present share price of US$4.29. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.
Happily, we note that in the last year insiders paid US$265k for 78.50k shares. But insiders sold 39.59k shares worth US$174k. Overall, DocGo insiders were net buyers during the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
DocGo is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Insider Ownership Of DocGo
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 7.5% of DocGo shares, worth about US$34m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
So What Does This Data Suggest About DocGo Insiders?
Insiders haven't bought DocGo stock in the last three months, but there was some selling. In contrast, they appear keener if you look at the last twelve months. It's good to see insiders are shareholders. So we're happy enough to look past some selling. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing DocGo. Our analysis shows 2 warning signs for DocGo (1 is a bit concerning!) and we strongly recommend you look at them before investing.
But note: DocGo may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:DCGO
DocGo
Provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom.
Solid track record with excellent balance sheet.